Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs in Type 2 Diabetes
NCT02302599Phase 2Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2013
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus (T2DM), sponsored by Chinese PLA General Hospital. Started Jan 2013; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02302599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302599.